Results 61 to 70 of about 6,085,130 (251)

Treatment for intermediate and advanced-stage hepatocellular carcinoma: does systemic therapy synergize the therapeutic efficacy of TACE?

open access: yesFrontiers in Immunology
BackgroundTransarterial chemoembolization (TACE) is a standard treatment for intermediate-stage hepatocellular carcinoma (HCC), but its efficacy varies due to patient heterogeneity.
Zhuo Li   +5 more
doaj   +1 more source

Evidence‐Based Clinical Practice Guidelines for the Management of Pediatric Febrile Neutropenia: Resource‐Sensitive Recommendations for the Asian Continent

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Febrile neutropenia (FN) is a frequent and serious complication in children receiving cancer therapy. Standardizing FN management across Asia is challenging due to variable healthcare infrastructure, diagnostic capacity, and infection patterns; however, it could improve resource use and patient outcomes.
Joliza Patricia Cañeba   +29 more
wiley   +1 more source

Femtosecond laser-assisted LASIK in the SMILE era: a mini review of patient-centered procedure selection

open access: yesFrontiers in Medicine
Femtosecond laser-assisted in situ keratomileusis (FS-LASIK) remains a mature corneal refractive procedure, but its role is being reshaped by small-incision lenticule extraction (SMILE), transepithelial photorefractive keratectomy, and phakic intraocular
Zitong Yu, Tong Qin
doaj   +1 more source

Patient selection.

open access: yes, 2017
Patient selection.
Masanao Tabuse (3639694)   +6 more
core   +1 more source

Abatacept for Prophylaxis of Acute and Chronic Graft‐Versus‐Host‐Disease in Children Undergoing Allogeneic Hematopoietic Stem Cell Transplantation—A Systematic Review and Meta‐Analysis of Cohort Studies

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Graft‐versus‐host disease (GvHD) remains one of the most significant complications of hematopoietic stem cell transplantation (HSCT). Abatacept, a selective T‐cell costimulation modulator, is a relatively novel prophylactic agent, though pediatric data remain limited.
Matthijs D. Kruizinga   +3 more
wiley   +1 more source

Other title: Title from HTML header (viewed Nov. 9, 2011): Judicial Selection Commission

open access: yes, 2011
Updated irregularly; Began in 2002?; Title from main search screen (publisher's Web site, viewed Nov. 9, 2011).; At head of title: State of Connecticut.; Harvested from the web on 11/10/11Official website of the Connecticut Judicial Selection Commission.

core   +1 more source

Outcomes of Donors in Living Donor Liver Transplantation: Effect of Strict Donor Selection Criteria

open access: yesJournal of Sharif Medical & Dental College
Objective: To evaluate the effect of strict institutional donor selection criteria on short term safety outcomes among living liver donors undergoing hepatectomy.
Muhammad Haroon   +4 more
doaj   +1 more source

Bone and Soft Tissue Neoplasms in Infants Versus Older Children: A Report From the Cancer in Young People in Canada Program

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background and Aims Infant bone and soft tissue neoplasms present distinct clinical challenges and lack large‐scale data to inform treatment decisions. This study aims to characterize bone and soft tissue neoplasms in infants in Canada and to compare their outcomes with those of older pediatric patients.
Samuel Sassine   +21 more
wiley   +1 more source

Efficacy and patient selection of consolidative thoracic radiotherapy following chemoimmunotherapy in ES-SCLC

open access: yesFrontiers in Cell and Developmental Biology
BackgroundDespite significant progress with immunotherapy in extensive-stage small-cell lung cancer (ES-SCLC), progression-free survival (PFS) remains limited, and relapse is common.
Donghong Yang   +11 more
doaj   +1 more source

Low‐dose hilar and mediastinal stereotactic body radiation therapy for non‐small cell lung cancer: Analysis of outcomes in patients receiving one or multiple courses of treatment

open access: yesThoracic Cancer, 2020
Background This study reports the outcomes of a single institutional experience treating non‐small cell lung cancer (NSCLC) involving the pulmonary hilum with low‐dose stereotactic body radiation therapy (SBRT).
Roman O. Kowalchuk   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy